Table 1 Correlation between FGL2 expression and clinicopathologic characteristics of ccRCC patients.
Characteristic | Cases | FGL2 expression | P b | |
---|---|---|---|---|
n = 170 | Low(n = 67) | High(n = 103) | ||
Gender | Â | Â | Â | 0.997 |
  Male | 104 (61.2%) | 41 | 63 |  |
  Female | 66 (38.8%) | 26 | 40 |  |
Age(years)a | Â | Â | Â | 0.225 |
  ≤55 | 96 (56.5%) | 34 | 62 |  |
  >55 | 74 (43.5%) | 33 | 41 |  |
Tunor size(cm)a | Â | Â | Â | 0.002* |
  ≤4 | 89 (52.4%) | 45 | 44 |  |
  >4 | 81(47.6%) | 22 | 59 |  |
T classification | Â | Â | Â | 0.003* |
  T1-T2 | 132 (77.6%) | 60 | 72 |  |
  T3-T4 | 38 (22.4%) | 7 | 31 |  |
N classification | Â | Â | Â | 0.266 |
  N0 | 162 (95.3%) | 62 | 100 |  |
  N1 | 8 (4.7%) | 5 | 3 |  |
TNM stage | Â | Â | Â | 0.002* |
  I-II | 138 (81.2%) | 62 | 76 |  |
  III-IV | 32 (18.8%) | 5 | 27 |  |
Fuhrman grade | Â | Â | Â | 0.763 |
  1-2 | 117 (68.8%) | 47 | 70 |  |
  3-4 | 53 (31.2%) | 20 | 33 |  |
Necrosis | Â | Â | Â | 0.714 |
  Absent | 153 (90%) | 61 | 92 |  |
  Present | 17 (10%) | 6 | 11 |  |